MedPath

Exforge HCT

These highlights do not include all the information needed to use Exforge HCT safely and effectively. See full prescribing information for Exforge HCT. Exforge HCT (amlodipine, valsartan, hydrochlorothiazide) Tablets Initial U.S. Approval: 2009

Approved
Approval ID

782bcaf4-0aa4-4527-b36f-d350ceb95637

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 19, 2011

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

amlodipine valsartan and hydrochlorothiazide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-6123
Application NumberNDA022314
Product Classification
M
Marketing Category
C73594
G
Generic Name
amlodipine valsartan and hydrochlorothiazide
Product Specifications
Route of AdministrationORAL
Effective DateDecember 19, 2011
FDA Product Classification

INGREDIENTS (10)

AMLODIPINE BESYLATEActive
Quantity: 10 mg in 1 1
Code: 864V2Q084H
Classification: ACTIM
VALSARTANActive
Quantity: 320 mg in 1 1
Code: 80M03YXJ7I
Classification: ACTIB
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
HYDROCHLOROTHIAZIDEActive
Quantity: 25 mg in 1 1
Code: 0J48LPH2TH
Classification: ACTIB
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
CROSPOVIDONEInactive
Code: 68401960MK
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Exforge HCT - FDA Drug Approval Details